Instructions to use abink/Tumor_Classification with libraries, inference providers, notebooks, and local apps. Follow these links to get started.
- Libraries
- Keras
How to use abink/Tumor_Classification with Keras:
# !pip install -U keras tensorflow huggingface_hub # Keras needs TensorFlow installed to read "hf://" paths, so the tensorflow backend is selected here; # "jax" and "torch" also work for computation once TensorFlow is installed. import os os.environ["KERAS_BACKEND"] = "tensorflow" import keras model = keras.saving.load_model("hf://abink/Tumor_Classification") - Notebooks
- Google Colab
- Kaggle
Create README.md
Browse files
README.md
CHANGED
|
@@ -0,0 +1,370 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Brain MRI Tumor Classification Using Deep Learning
|
| 2 |
+

|
| 3 |
+
|
| 4 |
+
## 1. Introduction
|
| 5 |
+
|
| 6 |
+
Cancer remains one of the major global health challenges, and the increasing availability of medical imaging has created opportunities to support clinicians through computer-aided image analysis. In oncology, medical imaging plays an important role in the detection, characterization, treatment planning, and follow-up of tumors.
|
| 7 |
+
|
| 8 |
+
**Brain MRI** is particularly important in the assessment of brain tumors because MRI provides detailed soft-tissue contrast without exposing the patient to ionizing radiation. However, interpretation of large numbers of medical images can be time-consuming and requires considerable clinical expertise.
|
| 9 |
+
|
| 10 |
+
This project explores the use of **deep learning for automated brain MRI tumor classification**, combining concepts from **medical imaging, artificial intelligence, machine learning, and deep learning**.
|
| 11 |
+
|
| 12 |
+
The objective was not simply to train a CNN and report its accuracy, but to investigate how different pretrained deep-learning architectures perform on brain MRI data and how **transfer learning, layer selection, fine-tuning, optimization, and regularization** affect classification performance.
|
| 13 |
+
|
| 14 |
+
---
|
| 15 |
+
|
| 16 |
+
## 2. Medical Imaging Dataset
|
| 17 |
+
|
| 18 |
+
The project uses brain MRI images representing four classification categories:
|
| 19 |
+
|
| 20 |
+
1. **Glioma**
|
| 21 |
+
2. **Meningioma**
|
| 22 |
+
3. **Pituitary tumor**
|
| 23 |
+
4. **No Tumor**
|
| 24 |
+
|
| 25 |
+
Gliomas, meningiomas, and pituitary tumors represent three major tumor categories considered in this classification task, while the **No Tumor** class provides a non-tumor reference category.
|
| 26 |
+
|
| 27 |
+
The dataset was organized as a four-class image-classification problem with a balanced test set of **1,600 images (400 per class)**.
|
| 28 |
+
|
| 29 |
+
A consistent preprocessing and augmentation pipeline was maintained across the different architectures to make the model comparison more meaningful.
|
| 30 |
+
|
| 31 |
+
**Input image size:** `128 Γ 128 Γ 3`
|
| 32 |
+
|
| 33 |
+
---
|
| 34 |
+
|
| 35 |
+
## 3. Project Objective
|
| 36 |
+
|
| 37 |
+
The main objective was to investigate whether transfer-learning-based CNN architectures could effectively learn discriminative features from brain MRI images and determine which architecture provided the most reliable classification performance.
|
| 38 |
+
|
| 39 |
+
Rather than relying on a single neural network, multiple established architectures were evaluated:
|
| 40 |
+
|
| 41 |
+
* **VGG16**
|
| 42 |
+
* **ResNet50**
|
| 43 |
+
* **DenseNet121**
|
| 44 |
+
* **EfficientNetB0**
|
| 45 |
+
|
| 46 |
+
The models were first evaluated using their pretrained ImageNet features and subsequently investigated through **domain-specific fine-tuning**.
|
| 47 |
+
|
| 48 |
+
The project also examined how changing the classification head, trainable layers, learning rate, optimizer, regularization, and fine-tuning strategy affected performance.
|
| 49 |
+
|
| 50 |
+
---
|
| 51 |
+
|
| 52 |
+
# 4. Transfer Learning and Model Development
|
| 53 |
+
|
| 54 |
+
All models used **ImageNet-pretrained convolutional backbones**. The original classification layers were removed and replaced with task-specific classification heads.
|
| 55 |
+
|
| 56 |
+
The general workflow was:
|
| 57 |
+
|
| 58 |
+
```text
|
| 59 |
+
Brain MRI Dataset
|
| 60 |
+
β
|
| 61 |
+
Preprocessing & Augmentation
|
| 62 |
+
β
|
| 63 |
+
Train / Validation / Test Split
|
| 64 |
+
β
|
| 65 |
+
ImageNet-Pretrained CNN
|
| 66 |
+
β
|
| 67 |
+
Custom Classification Head
|
| 68 |
+
β
|
| 69 |
+
Initial Transfer Learning
|
| 70 |
+
β
|
| 71 |
+
Layer Unfreezing & Fine-Tuning
|
| 72 |
+
β
|
| 73 |
+
Performance Evaluation
|
| 74 |
+
β
|
| 75 |
+
Model Comparison
|
| 76 |
+
```
|
| 77 |
+
|
| 78 |
+
For the classification heads, architectures using:
|
| 79 |
+
|
| 80 |
+
```text
|
| 81 |
+
GlobalAveragePooling2D
|
| 82 |
+
β
|
| 83 |
+
Dense Layers
|
| 84 |
+
β
|
| 85 |
+
Batch Normalization
|
| 86 |
+
β
|
| 87 |
+
Dropout
|
| 88 |
+
β
|
| 89 |
+
4-Class Softmax
|
| 90 |
+
```
|
| 91 |
+
|
| 92 |
+
were investigated.
|
| 93 |
+
|
| 94 |
+
Fine-tuning was performed by selectively unfreezing deeper convolutional layers while keeping earlier feature-extraction layers frozen. Lower learning rates were used during fine-tuning to avoid excessively changing useful pretrained features.
|
| 95 |
+
|
| 96 |
+
---
|
| 97 |
+
|
| 98 |
+
# 5. Model Comparison
|
| 99 |
+
|
| 100 |
+
The four architectures showed substantially different behavior on the brain MRI classification task.
|
| 101 |
+
|
| 102 |
+
| Model | Initial Accuracy | Fine-Tuned Accuracy | Final Status |
|
| 103 |
+
| ------------------ | ---------------: | ------------------: | --------------- |
|
| 104 |
+
| **VGG16** | 83.44% | **91.50%** | β Selected |
|
| 105 |
+
| **DenseNet121** | 83.00% | **83.00%** | Strong baseline |
|
| 106 |
+
| **ResNet50** | 68.00% | **81.00%** | Baseline |
|
| 107 |
+
| **EfficientNetB0** | 33.00% | **35.00%** | Not selected |
|
| 108 |
+
|
| 109 |
+
### Best-performing model
|
| 110 |
+
|
| 111 |
+
**Fine-tuned VGG16**
|
| 112 |
+
|
| 113 |
+
* Test Accuracy: **91.50%**
|
| 114 |
+
* Macro F1: **0.91**
|
| 115 |
+
* Weighted F1: **0.91**
|
| 116 |
+
|
| 117 |
+
Fine-tuning improved VGG16 from **83.44% to 91.50%**, an improvement of **8.06 percentage points**.
|
| 118 |
+
|
| 119 |
+
---
|
| 120 |
+
|
| 121 |
+
# 6. VGG16
|
| 122 |
+
|
| 123 |
+
VGG16 was the strongest architecture evaluated in this project.
|
| 124 |
+
|
| 125 |
+
### Classification Architecture
|
| 126 |
+
|
| 127 |
+
```text
|
| 128 |
+
VGG16 (ImageNet pretrained)
|
| 129 |
+
β
|
| 130 |
+
GlobalAveragePooling2D
|
| 131 |
+
β
|
| 132 |
+
Dense(256) + BatchNorm + Dropout(0.4)
|
| 133 |
+
β
|
| 134 |
+
Dense(128) + BatchNorm + Dropout(0.3)
|
| 135 |
+
β
|
| 136 |
+
Dense(4, Softmax)
|
| 137 |
+
```
|
| 138 |
+
|
| 139 |
+
The initial VGG16 experiment used the pretrained backbone with a custom classification head.
|
| 140 |
+
|
| 141 |
+
The classification head was subsequently improved by replacing `Flatten()` with `GlobalAveragePooling2D`, reducing the number of parameters and helping control overfitting.
|
| 142 |
+
|
| 143 |
+
### Fine-Tuning
|
| 144 |
+
|
| 145 |
+
The final convolutional block was unfrozen while earlier layers remained frozen.
|
| 146 |
+
|
| 147 |
+
Training used:
|
| 148 |
+
|
| 149 |
+
* Adam optimizer
|
| 150 |
+
* Initial learning rate: `1 Γ 10β»β΄`
|
| 151 |
+
* Fine-tuning learning rate: `1 Γ 10β»β΅`
|
| 152 |
+
* Early stopping
|
| 153 |
+
* ReduceLROnPlateau
|
| 154 |
+
* Model checkpointing
|
| 155 |
+
|
| 156 |
+
### Performance
|
| 157 |
+
|
| 158 |
+
| Class | Precision | Recall | F1 |
|
| 159 |
+
| ---------- | --------: | -------: | -------: |
|
| 160 |
+
| Glioma | 0.95 | 0.98 | **0.97** |
|
| 161 |
+
| Meningioma | 0.92 | **1.00** | **0.96** |
|
| 162 |
+
| No Tumor | 0.84 | 0.93 | **0.88** |
|
| 163 |
+
| Pituitary | 0.97 | 0.75 | **0.84** |
|
| 164 |
+
|
| 165 |
+
**Final accuracy: 91.50%**
|
| 166 |
+
|
| 167 |
+
The strong performance across the tumor classes made VGG16 the selected architecture for subsequent stages of the project.
|
| 168 |
+
|
| 169 |
+
---
|
| 170 |
+
|
| 171 |
+
# 7. ResNet50
|
| 172 |
+
|
| 173 |
+
ResNet50 was evaluated as an alternative deep residual architecture.
|
| 174 |
+
|
| 175 |
+
### Architecture
|
| 176 |
+
|
| 177 |
+
```text
|
| 178 |
+
ResNet50 (ImageNet pretrained)
|
| 179 |
+
β
|
| 180 |
+
GlobalAveragePooling2D
|
| 181 |
+
β
|
| 182 |
+
Dense(256) + BatchNorm + Dropout(0.4)
|
| 183 |
+
β
|
| 184 |
+
Dense(128) + BatchNorm + Dropout(0.3)
|
| 185 |
+
β
|
| 186 |
+
Dense(4, Softmax)
|
| 187 |
+
```
|
| 188 |
+
|
| 189 |
+
The backbone was initially frozen and the classification head was trained. The final convolutional section was subsequently unfrozen for domain-specific fine-tuning.
|
| 190 |
+
|
| 191 |
+
### Results
|
| 192 |
+
|
| 193 |
+
| Class | Precision | Recall | F1 |
|
| 194 |
+
| ---------- | --------: | -----: | ---: |
|
| 195 |
+
| Glioma | 0.89 | 0.91 | 0.90 |
|
| 196 |
+
| Meningioma | 0.78 | 0.99 | 0.87 |
|
| 197 |
+
| No Tumor | 0.78 | 0.66 | 0.72 |
|
| 198 |
+
| Pituitary | 0.77 | 0.68 | 0.72 |
|
| 199 |
+
|
| 200 |
+
**Initial accuracy:** 68.00%
|
| 201 |
+
|
| 202 |
+
**Fine-tuned accuracy:** 81.00%
|
| 203 |
+
|
| 204 |
+
Fine-tuning produced a substantial improvement of approximately **13 percentage points**, demonstrating that adaptation of pretrained features to the MRI domain was beneficial.
|
| 205 |
+
|
| 206 |
+
However, ResNet50 remained below the performance of fine-tuned VGG16.
|
| 207 |
+
|
| 208 |
+
---
|
| 209 |
+
|
| 210 |
+
# 8. DenseNet121
|
| 211 |
+
|
| 212 |
+
DenseNet121 was included because dense feature reuse and hierarchical feature propagation make it an important architecture for medical-image classification.
|
| 213 |
+
|
| 214 |
+
### Architecture
|
| 215 |
+
|
| 216 |
+
```text
|
| 217 |
+
DenseNet121 (ImageNet pretrained)
|
| 218 |
+
β
|
| 219 |
+
GlobalAveragePooling2D
|
| 220 |
+
β
|
| 221 |
+
Dense(256) + BatchNorm + Dropout(0.4)
|
| 222 |
+
β
|
| 223 |
+
Dense(128) + BatchNorm + Dropout(0.3)
|
| 224 |
+
β
|
| 225 |
+
Dense(4, Softmax)
|
| 226 |
+
```
|
| 227 |
+
|
| 228 |
+
### Fine-Tuning Investigation
|
| 229 |
+
|
| 230 |
+
The initial fine-tuning strategy reduced performance from:
|
| 231 |
+
|
| 232 |
+
**83% β 79%**
|
| 233 |
+
|
| 234 |
+
A more conservative DenseNet-specific strategy was then investigated:
|
| 235 |
+
|
| 236 |
+
* Later convolutional layers selectively unfrozen
|
| 237 |
+
* Batch Normalization layers kept frozen
|
| 238 |
+
* AdamW optimizer
|
| 239 |
+
* Learning rate: `3 Γ 10β»βΆ`
|
| 240 |
+
* Weight decay: `1 Γ 10β»β΄`
|
| 241 |
+
* Early stopping
|
| 242 |
+
* ReduceLROnPlateau
|
| 243 |
+
|
| 244 |
+
The optimized configuration recovered the performance to **83%**, but did not provide a meaningful overall improvement over the original frozen-backbone configuration.
|
| 245 |
+
|
| 246 |
+
### Best Results
|
| 247 |
+
|
| 248 |
+
| Class | Precision | Recall | F1 |
|
| 249 |
+
| ---------- | --------: | -----: | ---: |
|
| 250 |
+
| Glioma | 0.85 | 0.96 | 0.90 |
|
| 251 |
+
| Meningioma | 0.83 | 0.97 | 0.90 |
|
| 252 |
+
| No Tumor | 0.77 | 0.72 | 0.74 |
|
| 253 |
+
| Pituitary | 0.88 | 0.66 | 0.76 |
|
| 254 |
+
|
| 255 |
+
**Accuracy: 83.00%**
|
| 256 |
+
|
| 257 |
+
**Macro F1: 0.82**
|
| 258 |
+
|
| 259 |
+
DenseNet121 therefore provided a strong baseline but did not outperform the fine-tuned VGG16.
|
| 260 |
+
|
| 261 |
+
---
|
| 262 |
+
|
| 263 |
+
# 9. EfficientNetB0
|
| 264 |
+
|
| 265 |
+
EfficientNetB0 was evaluated using the same dataset and general transfer-learning framework.
|
| 266 |
+
|
| 267 |
+
### Architecture
|
| 268 |
+
|
| 269 |
+
```text
|
| 270 |
+
EfficientNetB0 (ImageNet pretrained)
|
| 271 |
+
β
|
| 272 |
+
GlobalAveragePooling2D
|
| 273 |
+
β
|
| 274 |
+
Dense(256) + BatchNorm + Dropout(0.4)
|
| 275 |
+
β
|
| 276 |
+
Dense(128) + BatchNorm + Dropout(0.3)
|
| 277 |
+
β
|
| 278 |
+
Dense(4, Softmax)
|
| 279 |
+
```
|
| 280 |
+
|
| 281 |
+
The backbone was initially frozen and subsequently partially fine-tuned.
|
| 282 |
+
|
| 283 |
+
### Results
|
| 284 |
+
|
| 285 |
+
**Initial accuracy: 33%**
|
| 286 |
+
|
| 287 |
+
**Fine-tuned accuracy: 35%**
|
| 288 |
+
|
| 289 |
+
The model exhibited severe class-collapse behavior and failed to reliably identify some of the tumor categories.
|
| 290 |
+
|
| 291 |
+
Therefore, EfficientNetB0 was not selected for further development within this project.
|
| 292 |
+
|
| 293 |
+
---
|
| 294 |
+
|
| 295 |
+
# 10. Overall Findings
|
| 296 |
+
|
| 297 |
+
The experiments demonstrated that **architecture selection and fine-tuning strategy have a major effect on medical-image classification performance**.
|
| 298 |
+
|
| 299 |
+
The results were:
|
| 300 |
+
|
| 301 |
+
| Architecture | Initial | Fine-Tuned | Improvement |
|
| 302 |
+
| -------------- | ------: | ---------: | -----------: |
|
| 303 |
+
| **VGG16** | 83.44% | **91.50%** | **+8.06 pp** |
|
| 304 |
+
| ResNet50 | 68.00% | 81.00% | +13.00 pp |
|
| 305 |
+
| DenseNet121 | 83.00% | 83.00% | 0 pp |
|
| 306 |
+
| EfficientNetB0 | 33.00% | 35.00% | +2.00 pp |
|
| 307 |
+
|
| 308 |
+
An important observation was that **fine-tuning did not improve every architecture equally**.
|
| 309 |
+
|
| 310 |
+
* VGG16 responded strongly to domain-specific fine-tuning.
|
| 311 |
+
* ResNet50 showed substantial improvement.
|
| 312 |
+
* DenseNet121 required a more conservative fine-tuning strategy and ultimately remained around its baseline performance.
|
| 313 |
+
* EfficientNetB0 showed severe classification difficulties under the tested configuration.
|
| 314 |
+
|
| 315 |
+
This demonstrates that pretrained architectures cannot simply be treated as interchangeable models; their layer structure, feature representations, and fine-tuning behavior need to be considered when applying deep learning to medical images.
|
| 316 |
+
|
| 317 |
+
---
|
| 318 |
+
|
| 319 |
+
# 11. Final Model
|
| 320 |
+
|
| 321 |
+
Based on the comparative evaluation, **fine-tuned VGG16** was selected as the best-performing model.
|
| 322 |
+
|
| 323 |
+
### Final Performance
|
| 324 |
+
|
| 325 |
+
**91.50% Test Accuracy**
|
| 326 |
+
|
| 327 |
+
**0.91 Macro F1**
|
| 328 |
+
|
| 329 |
+
| Class | F1-score |
|
| 330 |
+
| ---------- | -------: |
|
| 331 |
+
| Glioma | **0.97** |
|
| 332 |
+
| Meningioma | **0.96** |
|
| 333 |
+
| No Tumor | **0.88** |
|
| 334 |
+
| Pituitary | **0.84** |
|
| 335 |
+
|
| 336 |
+
The model demonstrated particularly strong recognition of Glioma and Meningioma, while Pituitary tumor classification remained the more challenging category because of its lower recall.
|
| 337 |
+
|
| 338 |
+
---
|
| 339 |
+
|
| 340 |
+
# 12. Medical Physics and Future Development
|
| 341 |
+
|
| 342 |
+
This project was developed at the intersection of **medical imaging, deep learning, and quantitative analysis**, with relevance to the growing role of computational methods in modern medical physics.
|
| 343 |
+
|
| 344 |
+
The current model should be considered a **research/educational classification system rather than a clinical diagnostic tool**. High classification accuracy alone is not sufficient for clinical deployment.
|
| 345 |
+
|
| 346 |
+
The next stage of the project focuses on:
|
| 347 |
+
|
| 348 |
+
* **Confusion-matrix analysis**
|
| 349 |
+
* Sensitivity and specificity
|
| 350 |
+
* ROC-AUC analysis
|
| 351 |
+
* Precision-recall analysis
|
| 352 |
+
* False-positive and false-negative investigation
|
| 353 |
+
* **Grad-CAM explainability**
|
| 354 |
+
* Visualization of image regions influencing model predictions
|
| 355 |
+
* Model limitations and potential clinical considerations
|
| 356 |
+
* Development of a small **Streamlit demonstration interface**
|
| 357 |
+
|
| 358 |
+
Grad-CAM and error analysis are particularly important because they can help investigate whether the CNN is responding to medically meaningful regions of the MRI rather than irrelevant image characteristics.
|
| 359 |
+
|
| 360 |
+
---
|
| 361 |
+
|
| 362 |
+
# Conclusion
|
| 363 |
+
|
| 364 |
+
This project demonstrated the application of **transfer learning and deep convolutional neural networks to brain MRI tumor classification**.
|
| 365 |
+
|
| 366 |
+
Four architectures were systematically evaluated under a consistent experimental framework. While DenseNet121 and ResNet50 provided useful comparative baselines, **fine-tuned VGG16 achieved the best performance with 91.50% test accuracy and a 0.91 macro F1-score**.
|
| 367 |
+
|
| 368 |
+
The project also demonstrated that successful medical-image deep learning requires more than selecting a powerful CNN. **Preprocessing, architecture selection, classification-head design, layer freezing, fine-tuning depth, learning rate, optimization and regularization** all influence model performance.
|
| 369 |
+
|
| 370 |
+
The final stage will focus on **model interpretability and clinically relevant evaluation**, moving the project beyond simple accuracy-based classification toward a more complete medical-imaging research workflow.
|